MabVax Therapeutics Story Overview

MBVX -- USA Stock  

USD 0.30  0.03  9.09%

Macroaxis does not monitor all media channels or aggregates social signals for MabVax Therapeutics. But even though we do not provide professional-grade financial sentiment analysis on MabVax Therapeutics, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for MabVax Therapeutics. Please see also MabVax Therapeutics Hype Analysis, MabVax Therapeutics Correlation and MabVax Therapeutics Performance.
Mabvax Therapeutics Holdings Inc Stock Price Performance in Focus
The Business UnionStock-research Ratings MabVax Therapeutics Holdings, Inc. , Digital Ally, Inc. Analyst JournalFull coverage

Read More...   

Story Momentum

This media report from earlebusinessunion.com distributed on December 7, 2017 was a factor to the next trading day price decrease.The trading delta at closing time against the next closing price was 1.52% . The trading delta at closing time when the story was published against the current closing price is 67.74% .

Similar stores for MabVax Therapeutics

over a week ago at http://baycityobserver.com 
What Can the Quant Signals Tell us About These Stocks MabVax Therapeutics Holdings, Inc. , Cohiba ...
news
Bay City ObserverFull coverage
over a month ago at http://cardinalweekly.com 
Web.com Group, Inc. Analysts See 0.19 EPS
news
The Cardinal Weekly EPS for Web.com Group, Inc. Expected At 0.19 Thorold NewsFull coverage
over a month ago at http://stocknewsgazette.com 
Its worth it to have a look at News Corporation
news
StockNewsGazetteFull coverage
over a month ago at http://www.law360.com 
MabVax Corporate Acts Marred By Pump And Dump Validated
news
Law360Full coverage
over two months ago at http://markets.businessinsider.com 
Investor Alert Kaplan Fox Investigates OPKO Health, Inc.
businessinsider News
Markets InsiderFull coverage
over two months ago at http://www.thecoinguild.com 
Exchange View Checking in on Shares of MabVax Therapeutics Holdings, Inc.
news
The Coin GuildFull coverage
over two months ago at http://thewellesleysnews.com 
Analyst Stock Recommendations For Newater Technology, Inc. , MabVax Therapeutics Holdings, Inc.
news
Analyst JournalFull coverage
over two months ago at http://cedarvillenews.com 
MabVax Therapeutics Holdings, Inc. s Target Weight Reaches 0.44
news
Cedarville NewsFull coverage
over three months ago at http://www.baseballdailydigest.com 
144.07 Million in Sales Expected for First Interstate Bancsystem Inc This Quarter
news
Baseball Daily DigestFull coverage
over three months ago at http://www.thecoinguild.com 
Equity Review Checking in on Shares of MabVax Therapeutics Holdings, Inc.
news
The Coin GuildFull coverage
over three months ago at www.macroaxis.com 
Purchase by Wick Michael M of 4600 shares of MabVax Therapeutics
Macroaxis News
Filed transaction by Mabvax Therapeutics Holdi director. General open market or private purchase of non-derivative or derivative security
over six months ago at http://www.stocksnewspoint.com 
MabVax Therapeutics Holdings, Inc. , ARC Document Solutions, Inc. Trend Analysis ...
news
Stocks News Point Full coverage
over six months ago at http://postanalyst.com 
MabVax Therapeutics Holdings, Inc. A Detailed Look at its Institutional Ownership
news
Post AnalystA Comparison of Top Movers Sea Limited , MabVax Therapeutics Holdings, Inc. StockNewsGazetteMabVax Therapeutics Holdings, Inc. Hot Stock Analysis Nasdaq JournalFull coverage

Gross Profit

Gross Profit Comparative Analysis

  Gross Profit 
      MabVax Therapeutics Comparables 
MabVax Therapeutics is currently under evaluation in gross profit category among related companies. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Peers

MabVax Therapeutics Related Equities

VRTX  5.04   
0%
100.0%
CELG  3.38   
0%
66.0%
CSLLY  2.59   
0%
51.0%
BIIB  1.71   
0%
33.0%
SHPG  1.04   
0%
20.0%
NVO  0.18   
0%
3.0%
AMGN  0.03   
1.0%
0%
GILD  0.08   
1.0%
0%
NONOF  0.72   
14.0%
0%
SHPGF  2.49   
49.0%
0%
Please see also MabVax Therapeutics Hype Analysis, MabVax Therapeutics Correlation and MabVax Therapeutics Performance. Please also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Search macroaxis.com